Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: An immunohistochemical analysis with automated cellular imaging

Anirban Maitra, Raheela Ashfaq, Carla R. Gunn, Ayman Rahman, Charles J. Yeo, Taylor A. Sohn, John L. Cameron, Ralph H. Hruban, Robb E. Wilentz

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

We immunohistochemically examined material from 36 pancreata (adenocarcinomas, 30 lesions; pancreatic intraepithelial neoplasia [PanIN], 65; normal pancreatic ducts, 30) for cyclooxygenase 2 (COX-2) with an automated platform. We analyzed 7 to 10 discrete foci and generated an average percentage of positive cells and average staining intensity for each lesion. These 2 values were then multiplied to create an overall "HistoScore" for each lesion. COX-2 demonstrated considerable heterogeneity of expression between and within cases. The overall average percentage of positive cells in adenocarcinomas was 47.3%; in PanINs, 36.3%; and in normal ducts, 19.2%. COX-2 was expressed in more than 20% of cells in 23 adenocarcinomas (77%), 42 PanINs (65%), and 12 normal ducts (40%). The overall average HistoScore for adenocarcinomas was 6.1; for PanINs, 5.4; and for normal ducts, 3.5. Significant differences in COX-2 expression were demonstrable in adenocarcinomas vs normal ducts, PanINs vs normal ducts, and PanIN 2/3 vs PanIN 1a/1b. In general, the patient of COX-2 expression increased from normal to PanIN to adenocarcinoma. The up-regulation of COX-2 in a subset of noninvasive precursor lesions makes it a potential target for chemoprevention with selective COX-2 inhibitors.

Original languageEnglish (US)
Pages (from-to)194-201
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume118
Issue number2
DOIs
StatePublished - Aug 2002
Externally publishedYes

Fingerprint

Cyclooxygenase 2
Adenocarcinoma
Neoplasms
Pancreatic Ducts
Cyclooxygenase 2 Inhibitors
Chemoprevention
Adenocarcinoma in Situ
Pancreas
Up-Regulation
Staining and Labeling

Keywords

  • Cyclooxygenase 2
  • Image analysis
  • Pancreatic adenocarcinoma
  • Pancreatic intraepithelial neoplasia
  • PanIN

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia : An immunohistochemical analysis with automated cellular imaging. / Maitra, Anirban; Ashfaq, Raheela; Gunn, Carla R.; Rahman, Ayman; Yeo, Charles J.; Sohn, Taylor A.; Cameron, John L.; Hruban, Ralph H.; Wilentz, Robb E.

In: American Journal of Clinical Pathology, Vol. 118, No. 2, 08.2002, p. 194-201.

Research output: Contribution to journalArticle

Maitra, Anirban ; Ashfaq, Raheela ; Gunn, Carla R. ; Rahman, Ayman ; Yeo, Charles J. ; Sohn, Taylor A. ; Cameron, John L. ; Hruban, Ralph H. ; Wilentz, Robb E. / Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia : An immunohistochemical analysis with automated cellular imaging. In: American Journal of Clinical Pathology. 2002 ; Vol. 118, No. 2. pp. 194-201.
@article{d3ea6555204d4df384a71e1146eab69f,
title = "Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: An immunohistochemical analysis with automated cellular imaging",
abstract = "We immunohistochemically examined material from 36 pancreata (adenocarcinomas, 30 lesions; pancreatic intraepithelial neoplasia [PanIN], 65; normal pancreatic ducts, 30) for cyclooxygenase 2 (COX-2) with an automated platform. We analyzed 7 to 10 discrete foci and generated an average percentage of positive cells and average staining intensity for each lesion. These 2 values were then multiplied to create an overall {"}HistoScore{"} for each lesion. COX-2 demonstrated considerable heterogeneity of expression between and within cases. The overall average percentage of positive cells in adenocarcinomas was 47.3{\%}; in PanINs, 36.3{\%}; and in normal ducts, 19.2{\%}. COX-2 was expressed in more than 20{\%} of cells in 23 adenocarcinomas (77{\%}), 42 PanINs (65{\%}), and 12 normal ducts (40{\%}). The overall average HistoScore for adenocarcinomas was 6.1; for PanINs, 5.4; and for normal ducts, 3.5. Significant differences in COX-2 expression were demonstrable in adenocarcinomas vs normal ducts, PanINs vs normal ducts, and PanIN 2/3 vs PanIN 1a/1b. In general, the patient of COX-2 expression increased from normal to PanIN to adenocarcinoma. The up-regulation of COX-2 in a subset of noninvasive precursor lesions makes it a potential target for chemoprevention with selective COX-2 inhibitors.",
keywords = "Cyclooxygenase 2, Image analysis, Pancreatic adenocarcinoma, Pancreatic intraepithelial neoplasia, PanIN",
author = "Anirban Maitra and Raheela Ashfaq and Gunn, {Carla R.} and Ayman Rahman and Yeo, {Charles J.} and Sohn, {Taylor A.} and Cameron, {John L.} and Hruban, {Ralph H.} and Wilentz, {Robb E.}",
year = "2002",
month = "8",
doi = "10.1309/TPG4-CK1C-9V8V-8AWC",
language = "English (US)",
volume = "118",
pages = "194--201",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia

T2 - An immunohistochemical analysis with automated cellular imaging

AU - Maitra, Anirban

AU - Ashfaq, Raheela

AU - Gunn, Carla R.

AU - Rahman, Ayman

AU - Yeo, Charles J.

AU - Sohn, Taylor A.

AU - Cameron, John L.

AU - Hruban, Ralph H.

AU - Wilentz, Robb E.

PY - 2002/8

Y1 - 2002/8

N2 - We immunohistochemically examined material from 36 pancreata (adenocarcinomas, 30 lesions; pancreatic intraepithelial neoplasia [PanIN], 65; normal pancreatic ducts, 30) for cyclooxygenase 2 (COX-2) with an automated platform. We analyzed 7 to 10 discrete foci and generated an average percentage of positive cells and average staining intensity for each lesion. These 2 values were then multiplied to create an overall "HistoScore" for each lesion. COX-2 demonstrated considerable heterogeneity of expression between and within cases. The overall average percentage of positive cells in adenocarcinomas was 47.3%; in PanINs, 36.3%; and in normal ducts, 19.2%. COX-2 was expressed in more than 20% of cells in 23 adenocarcinomas (77%), 42 PanINs (65%), and 12 normal ducts (40%). The overall average HistoScore for adenocarcinomas was 6.1; for PanINs, 5.4; and for normal ducts, 3.5. Significant differences in COX-2 expression were demonstrable in adenocarcinomas vs normal ducts, PanINs vs normal ducts, and PanIN 2/3 vs PanIN 1a/1b. In general, the patient of COX-2 expression increased from normal to PanIN to adenocarcinoma. The up-regulation of COX-2 in a subset of noninvasive precursor lesions makes it a potential target for chemoprevention with selective COX-2 inhibitors.

AB - We immunohistochemically examined material from 36 pancreata (adenocarcinomas, 30 lesions; pancreatic intraepithelial neoplasia [PanIN], 65; normal pancreatic ducts, 30) for cyclooxygenase 2 (COX-2) with an automated platform. We analyzed 7 to 10 discrete foci and generated an average percentage of positive cells and average staining intensity for each lesion. These 2 values were then multiplied to create an overall "HistoScore" for each lesion. COX-2 demonstrated considerable heterogeneity of expression between and within cases. The overall average percentage of positive cells in adenocarcinomas was 47.3%; in PanINs, 36.3%; and in normal ducts, 19.2%. COX-2 was expressed in more than 20% of cells in 23 adenocarcinomas (77%), 42 PanINs (65%), and 12 normal ducts (40%). The overall average HistoScore for adenocarcinomas was 6.1; for PanINs, 5.4; and for normal ducts, 3.5. Significant differences in COX-2 expression were demonstrable in adenocarcinomas vs normal ducts, PanINs vs normal ducts, and PanIN 2/3 vs PanIN 1a/1b. In general, the patient of COX-2 expression increased from normal to PanIN to adenocarcinoma. The up-regulation of COX-2 in a subset of noninvasive precursor lesions makes it a potential target for chemoprevention with selective COX-2 inhibitors.

KW - Cyclooxygenase 2

KW - Image analysis

KW - Pancreatic adenocarcinoma

KW - Pancreatic intraepithelial neoplasia

KW - PanIN

UR - http://www.scopus.com/inward/record.url?scp=0036672963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036672963&partnerID=8YFLogxK

U2 - 10.1309/TPG4-CK1C-9V8V-8AWC

DO - 10.1309/TPG4-CK1C-9V8V-8AWC

M3 - Article

C2 - 12162677

AN - SCOPUS:0036672963

VL - 118

SP - 194

EP - 201

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -